Bullboard - Stock Discussion Forum IBEX Technologies Inc V.IBT

Healthcare Biotechnology

IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a... see more

Add To Watchlist

TSXV:IBT - Post Discussion

IBEX Technologies Inc > Listed Competitors of IBT

View:

Post by nozzpack on Dec 18, 2021 10:19am

Listed Competitors of IBT

Brutally undervalued with a market cap of $11 m..

IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The firm also specializes in the custom aliquoting, filling, and lyophilization of enzymes in diagnostic disposables for medical devices. Its products include glycobiology enxymes, collagen assays, collagen antibodies, diamine oxidase liquid. The company was founded by Robert A. Heft on April 10, 1972 and is headquartered in Montral, Canada.

COMPETITORS

NAME	CHG %	MARKET CAP
Spectral Medical Inc.	7.84%	$68.31M
Ceapro Inc.	4.00%	$38.84M
Burcon NutraScience Corp.	4.29%	$152.12M
Microbix Biosystems Inc.	1.47%	$84.25M
	-

135

Comment

Comment by prophetoffacts on Dec 18, 2021 11:26am

This post has been removed in accordance with Community Policy

Comment by nozzpack on Dec 18, 2021 1:39pm

Ceapro talk the talk but very slow to walk the walk. Been there already, just like Jemtec which has no growth profile and limited market. IBT shines by example..

Comment